SS
THRD

Steve Schonfeld’s Third Harmonic Bio THRD Stock Holding History

Steve Schonfeld’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-770,800
Closed -$4.19M – 2581
2025
Q2 		$4.19M Buy
770,800
+740,694
+2,460% +$3.69M 0.03% 622
2025
Q1 		$104K Sell
30,106
-292,096
-91% -$1.42M ﹤0.01% 2017
2024
Q4 		$3.32M Buy
322,202
+65,900
+26% +$821K 0.02% 633
2024
Q3 		$3.47M Sell
256,302
-73,948
-22% -$916K 0.02% 665
2024
Q2 		$4.29M Buy
330,250
+120,750
+58% +$1.49M 0.03% 604
2024
Q1 		$1.98M Buy
+209,500
New +$2.04M 0.01% 996

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Steve Schonfeld's THRD Position: Q3 2025 in Review

Steve Schonfeld sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 770,800 shares — an estimated $4.19M sold.

Steve Schonfeld first reported a position in THRD in Q1 2024 and held it in 6 quarters. The position peaked at $4.29M in Q2 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Steve Schonfeld reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Steve Schonfeld sold 770,800 Third Harmonic Bio shares in Q3 2025, an estimated $4.19M.
  • Steve Schonfeld first reported a position in Third Harmonic Bio in Q1 2024 and held it in 6 quarters.
  • Steve Schonfeld's Third Harmonic Bio position peaked at $4.29M in Q2 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.